Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip & Microfluidics World Congress 2019

Leanna Levine's Biography



Leanna Levine, President & CEO, ALine, Inc.

Dr. Levine, founder of ALine, Inc. conceived and developed ALine’s unique and proprietary fabrication platform that permits rapid prototyping and volume manufacture of highly functional microfluidic and lab-on-chip devices. Under her leadership, the company has developed instrumentation and a unique tool box of functions that have seen commercial application for single-use products. ALine has created a disposable design strategy that can be generally applied for a variety of multiplexed, quantitative diagnostic or field-portable tests. Prior to founding ALine, Dr. Levine’s lab lead the industry in the application of fluorescence polarization for high throughput screening of enzyme targets, now an industry standard detection method in fluorescent plate readers. In 1998 she joined Spectrum Laboratories as Director of Manufacturing and Product Development where she developed a novel fiber-in-fiber spinning method for hollow fiber membranes. Her unique combination of scientific research skills and manufacturing expertise has played a significant role in creating a bridge from research innovations into viable product opportunities. Dr. Levine earned her PhD at Washington University, St. Louis (1986), and her BS in Biochemistry and BA in German from the University of Missouri, Columbia, MO (1982). In 2003 she was a visiting scholar at the UCLA Anderson School of Business. In 2000 she was the chair of the Gordon Conference on Bioanalytical Sensors. She is the co-author on a dozen publications, and several patents.

Leanna Levine Image

Why Considering the Impact of Cartridge Architecture Matters for the Final Product Cost of Goods

Tuesday, 8 October 2019 at 15:30

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com

As microfluidics-based products mature and move toward the consumer market, the drive toward a lower cost of goods for the instrument, in addition to a low-cost consumable, requires consideration of the overall cartridge architecture and the instrument interface early in the development program. For example, choices in the valve design and actuation method can lead to the instrument, rather than the assay protocol, driving the cartridge design.  In this presentation, we will review examples and strategies that have been implemented in development programs, and provide context on the impact of different choices on the system, including impact on the size of the microfluidics-based consumable, and overall system  complexity.

Conference Chaiperson Opening Remarks and Welcome to the Attendees

Monday, 7 October 2019 at 13:40

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2019-10-07 00:00:002019-10-09 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics World Congress 2019Lab-on-a-Chip and Microfluidics World Congress 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com